It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Understanding when and how to adjust a zero based budget helps you stay aligned with goals. Explore timing, methods, and best practices.
28,408 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Ethereum eyes a base-building phase near $1,800 as traders weigh a rebound versus renewed downside risk in early 2026.
Oil's sudden jump rattled macro markets and prompted crypto traders to rethink bitcoin price prediction: just as BTC ...
United Wholesale Mortgage reports a profitable first quarter as originations slow. CEO Mat Ishbia escalates pressure ...
Bitcoin slid below 78,000 over the weekend, prompting a surge in downside hedging as traders priced in volatility and...
A sharp Friday selloff in tech stocks gave way to Monday gains as AI-driven names rebound, signaling that the trade’s...
Oil traders weigh the risk of a rush of Iranian crude if sanctions ease, potentially easing inflation but complicatin...
A timely look at two Roth conversion advantages highlighted by Dave Ramsey. The piece explains how these perks could ...
Coinbase reports a resilient services business while MicroStrategy shoulders heavy bitcoin exposure and fixed costs a...
A 2.8% cost-of-living bump boosts checks in January, but higher Medicare costs and a government scheduling overhaul m...
Bitcoin revives after a tough stretch as geopolitical risk cools and oil markets settle. Traders monitor ETF momentum...
Bitcoin harbors a tense battlefield near the $80,000 zone as aging coins hit the market and institutional buyers abso...